Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (551-560 of 684) with videos related to

Pageof 69
Sort By:
Nature Communications|January 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinomaAmin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening TrialsSteven J Skates, Mark H Greene, Saundra S Buys, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.
British Journal of Cancer|March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association ConsortiumSuzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
International Journal of Cancer|August 31, 2019
Identification of novel epithelial ovarian cancer loci in women of African ancestryAni Manichaikul, Lauren C Peres, Xin-Qun Wang, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Pageof 69

Showing results (551-560 of 684) with videos related to

Sort By:
Pageof 69
Nature Communications|January 21, 2023
Epigenomic charting and functional annotation of risk loci in renal cell carcinomaAmin H Nassar, Sarah Abou Alaiwi, Sylvan C Baca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2017
Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening TrialsSteven J Skates, Mark H Greene, Saundra S Buys, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Human Molecular Genetics|March 23, 2011
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer riskCeleste Leigh Pearce, Jennifer A Doherty, David J Van Den Berg, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports|June 13, 2024
Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinomaTalal El Zarif, Karl Semaan, Marc Eid, et al.
British Journal of Cancer|March 29, 2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association ConsortiumSuzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, et al.
International Journal of Cancer|August 31, 2019
Identification of novel epithelial ovarian cancer loci in women of African ancestryAni Manichaikul, Lauren C Peres, Xin-Qun Wang, et al.
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.
Pageof 69